Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This study focuses on the production side and consumption side of Asthma and COPD Drug, presents the global Asthma and COPD Drug market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. In terms of production side, this report researches the Asthma and COPD Drug capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type. In terms of consumption side, this report focuses on the consumption of Asthma and COPD Drug by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc. Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life. The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided. The Asthma and COPD Drug market was valued at 5200 Million US$ in 2017 and is projected to reach 8040 Million US$ by 2025, at a CAGR of 5.6% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Asthma and COPD Drug.
This report elaborates on the current development of the Asthma and COPD Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
F Hoffmann-La Roche
Merck and Co
Novartis AG
Boehringer Ingelheim
AstraZeneca
By Type:
Monoclonal Antibodies
Anti-inflammatory Drugs
Combination Drugs
Bronchodilators
By Application:
Asthma
COPD
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Asthma and COPD Drug Market Overview 2018-2029
-
1.1 China Asthma and COPD Drug Industry Development Overview
-
1.2 China Asthma and COPD Drug Industry Development History
-
1.3 China Asthma and COPD Drug Industry Market Size (2018-2029)
-
1.4 China Asthma and COPD Drug Market Analysis by Type from Production Side
-
1.4.1 China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.2 China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Anti-inflammatory Drugs (2018-2029)
-
1.4.3 China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Combination Drugs (2018-2029)
-
1.4.4 China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Bronchodilators (2018-2029)
-
1.5 China Asthma and COPD Drug Market Analysis by Application from Consumption End
-
1.5.1 China Asthma and COPD Drug Sales Volume, Sales Value and Growth Rate of Asthma (2018-2029)
-
1.5.2 China Asthma and COPD Drug Sales Volume, Sales Value and Growth Rate of COPD (2018-2029)
-
1.6 China Asthma and COPD Drug Market Analysis by Region
-
1.6.1 North China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Asthma and COPD Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Asthma and COPD Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Asthma and COPD Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Asthma and COPD Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Asthma and COPD Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Asthma and COPD Drug Industry Development
Chapter 3 Asthma and COPD DrugIndustry Chain Analysis
-
3.1 Asthma and COPD Drug Industry Chain
-
3.2 Asthma and COPD Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Asthma and COPD Drug Market
-
3.3 Asthma and COPD Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Asthma and COPD Drug Market
Chapter 4 China Asthma and COPD Drug Market, by Type
-
4.1 China Asthma and COPD Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Asthma and COPD Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Asthma and COPD Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Asthma and COPD Drug Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.2 China Asthma and COPD Drug Production Volume and Growth Rate of Anti-inflammatory Drugs
-
4.5.3 China Asthma and COPD Drug Production Volume and Growth Rate of Combination Drugs
-
4.5.4 China Asthma and COPD Drug Production Volume and Growth Rate of Bronchodilators
Chapter 5 China Asthma and COPD Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Asthma and COPD Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Asthma and COPD Drug Market Size and Growth Rate, by Application
-
5.5.1 China Asthma and COPD Drug Market Size and Growth Rate of Asthma
-
5.5.2 China Asthma and COPD Drug Market Size and Growth Rate of COPD
Chapter 6 China Asthma and COPD Drug Market, by Region
-
6.1 China Asthma and COPD Drug Production Volume and Production Value, by Region
-
6.2 China Asthma and COPD Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Asthma and COPD Drug Market Analysis
-
7.1 North China Asthma and COPD Drug Market, by Type
-
7.2 North China Asthma and COPD Drug Market, by Application
Chapter 8 Central China Asthma and COPD Drug Market Analysis
-
8.1 Central China Asthma and COPD Drug Market, by Type
-
8.2 Central China Asthma and COPD Drug Market, by Application
Chapter 9 South China Asthma and COPD Drug Market Analysis
-
9.1 South China Asthma and COPD Drug Market, by Type
-
9.2 South China Asthma and COPD Drug Market, by Application
Chapter 10 East China Asthma and COPD Drug Market Analysis
-
10.1 East China Asthma and COPD Drug Market, by Type
-
10.2 East China Asthma and COPD Drug Market, by Application
Chapter 11 Northeast China Asthma and COPD Drug Market Analysis
-
11.1 Northeast China Asthma and COPD Drug Market, by Type
-
11.2 Northeast China Asthma and COPD Drug Market, by Application
Chapter 12 Southwest China Asthma and COPD Drug Market Analysis
-
12.1 Southwest China Asthma and COPD Drug Market, by Type
-
12.2 Southwest China Asthma and COPD Drug Market, by Application
Chapter 13 Northwest China Asthma and COPD Drug Market Analysis
-
13.1 Northwest China Asthma and COPD Drug Market, by Type
-
13.2 Northwest China Asthma and COPD Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 F Hoffmann-La Roche
-
14.1.1 F Hoffmann-La Roche Company Profile
-
14.1.2 F Hoffmann-La Roche Asthma and COPD Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck and Co
-
14.2.1 Merck and Co Company Profile
-
14.2.2 Merck and Co Asthma and COPD Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Profile
-
14.3.2 Novartis AG Asthma and COPD Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Boehringer Ingelheim
-
14.4.1 Boehringer Ingelheim Company Profile
-
14.4.2 Boehringer Ingelheim Asthma and COPD Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Profile
-
14.5.2 AstraZeneca Asthma and COPD Drug Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Asthma and COPD Drug Industry Research Conclusions
-
15.2 Asthma and COPD Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Asthma and COPD Drug Industry Market Size (2018-2029)
-
Figure China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Anti-inflammatory Drugs (2018-2029)
-
Figure China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Combination Drugs (2018-2029)
-
Figure China Asthma and COPD Drug Production Volume, Production Value and Growth Rate of Bronchodilators (2018-2029)
-
Figure China Asthma and COPD Drug Sales Volume, Sales Value and Growth Rate of Asthma (2018-2029)
-
Figure China Asthma and COPD Drug Sales Volume, Sales Value and Growth Rate of COPD (2018-2029)
-
Figure North China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Asthma and COPD Drug Market Size and Growth Rate from 2018-2029
-
Figure Asthma and COPD Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Asthma and COPD Drug Market Share by Type in 2018
-
Figure China Asthma and COPD Drug Market Share by Type in 2023
-
Figure China Asthma and COPD Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Asthma and COPD Drug Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Asthma and COPD Drug Production Volume and Growth Rate of Anti-inflammatory Drugs (2018-2023)
-
Figure China Asthma and COPD Drug Production Volume and Growth Rate of Combination Drugs (2018-2023)
-
Figure China Asthma and COPD Drug Production Volume and Growth Rate of Bronchodilators (2018-2023)
-
Figure China Asthma and COPD Drug Market Share by Application in 2018
-
Figure China Asthma and COPD Drug Market Share by Application in 2023
-
Figure China Asthma and COPD Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Asthma and COPD Drug Market Size and Growth Rate of Asthma (2018-2023)
-
Figure China Asthma and COPD Drug Market Size and Growth Rate of COPD (2018-2023)
-
Table China Asthma and COPD Drug Production Volume by Region (2018-2023)
-
Table China Asthma and COPD Drug Production Volume Share by Region (2018-2023)
-
Figure China Asthma and COPD Drug Production Volume Share by Region (2018-2023)
-
Table China Asthma and COPD Drug Production Value by Region (2018-2023)
-
Table China Asthma and COPD Drug Production Value Share by Region (2018-2023)
-
Figure China Asthma and COPD Drug Production Value Share by Region (2018-2023)
-
Table China Asthma and COPD Drug Sales Volume by Region (2018-2023)
-
Table China Asthma and COPD Drug Sales Volume Share by Region (2018-2023)
-
Figure China Asthma and COPD Drug Sales Volume Share by Region (2018-2023)
-
Table China Asthma and COPD Drug Sales Value by Region (2018-2023)
-
Table China Asthma and COPD Drug Sales Value Share by Region (2018-2023)
-
Figure China Asthma and COPD Drug Sales Value Share by Region (2018-2023)
-
Table North China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table North China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure North China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table North China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table North China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table Central China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table Central China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table Central China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table South China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table South China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure South China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table South China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table South China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table East China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table East China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure East China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table East China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table East China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table Northeast China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table Southwest China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Asthma and COPD Drug Production Volume by Type (2018-2023)
-
Table Northwest China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Asthma and COPD Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Asthma and COPD Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Asthma and COPD Drug Sales Volume Share by Application (2018-2023)
-
Table F Hoffmann-La Roche Company Profile
-
Table F Hoffmann-La Roche Asthma and COPD Drug Revenue, Price and Gross (2018-2023)
-
Table Merck and Co Company Profile
-
Table Merck and Co Asthma and COPD Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Asthma and COPD Drug Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Asthma and COPD Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Asthma and COPD Drug Revenue, Price and Gross (2018-2023)
-
